Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company
October 29, 2024 15:28 ET
|
Tevogen Bio Inc
Regained compliance without effecting a reverse stock splitTevogen Bio CEO reaffirms his commitment to preserve shareholder value WARREN, N.J., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio...
EUDA Health Holdings Limited Has Regained Compliance with Nasdaq Capital Market’s Continued Listing Requirements After receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
January 16, 2024 18:15 ET
|
EUDA Health Holdings Limited
Singapore., Jan. 16, 2024 (GLOBE NEWSWIRE) -- As previously disclosed, EUDA Health Holdings Limited (“EUDA” and the “Company”) received a written notice from Nasdaq on January 9, 2024 indicating...
BIO-key Regains Compliance with Nasdaq Rule Requiring Timely Filing of Periodic Financial Reports Following Filing of its Q1’23 Form 10-Q with SEC
June 13, 2023 13:12 ET
|
BIO-key International, Inc.
WALL, N.J., June 13, 2023 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of workforce and customer identity and access management (IAM) solutions featuring...
Sify regains compliance with NASDAQ Minimum Bid Price requirement
August 18, 2020 10:23 ET
|
Sify Technologies Limited
Santa Clara, California, Aug. 18, 2020 (GLOBE NEWSWIRE) -- Sify Technologies Limited (NASDAQ: SIFY), headquartered in Chennai, India, India’s most comprehensive ICT solutions provider with global...